StonvexLoading…
StonvexStonvexStonvexCore line items from CRVL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Annual 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $709.98M | $474.35M | $234.71M | $895.59M |
Operating Income | $103.42M | $71.18M | $35.28M | $120.82M |
Net Income | $79.31M | $55.14M | $27.23M | $95.17M |
EPS (Diluted) | $1.53 | $1.06 | $0.52 | $1.83 |
Total Assets | $644.78M | $611.68M | $597.45M | $545.98M |
Total Liabilities | $269.06M | $248.90M | $254.92M | $223.99M |
Cash & Equivalents | $230.03M | $207.45M | $202.03M | $170.58M |
Free Cash Flow OCF − CapEx | $89.99M | $54.82M | $39.55M | $91.56M |
Shares Outstanding | 51.14M | 51.29M | 51.33M | 51.36M |